The Maryland Senate has unanimously approved a bill to extend a psychedelics task force through the end of 2027 to develop updated recommendations on expanding therapeutic access to the novel drugs and potentially creating a regulatory framework for broader legalization.
Just days after moving through committee—which came on the same day that the House of Delegates passed that chamber’s version—the full Senate on Thursday approved the legislation from Sen. Brian Feldman (D) in a 44-0 vote.
Both chambers’ proposals are aimed at building upon a current law that created the Maryland Task Force on Responsible Use of Natural Psychedelic Substances.
That panel released an initial final report to state lawmakers last year, with recommendations for the phased implementation of a wide range of reforms to provide legal therapeutic access to substances such as psilocybin.
“The mission was to study the use of natural psychedelic substances and make recommendations regarding changes to state law, policy and practices to create a Maryland natural psychedelic substance access program and to make recommendations to transition from the criminalization of these substances,” Feldman said at a committee hearing earlier this month. “This is a really hard-working group of individuals.”
Members of the task force
Read full article on Marijuana Moment
